Lactate Dehydrogenase A Facilitates Sorbitol and Fructose Metabolism in Tumor Cells

Overview

This study demonstrates that lactate dehydrogenase A (LDHA) plays a significant role in the metabolism of sorbitol and fructose in hypoxic U87MG tumor cells. LDHA knockdown reduces fructose levels and cell viability, while its overexpression has the opposite effect.

Background

Understanding tumor metabolism is crucial for developing effective cancer therapies. The polyol pathway, which converts glucose to fructose, has been implicated in tumor cell metabolism under hypoxic conditions. This study explores the role of LDHA in this metabolic process, particularly in tumor cells with low sorbitol dehydrogenase expression.

Data Highlights

Key Findings

• LDHA is increased in hypoxic U87MG cells.
• LDHA catalyzes sorbitol oxidation and fructose reduction in vitro.
• LDHA knockdown leads to reduced fructose and increased sorbitol accumulation.
• Increased reactive oxygen species (ROS) levels are observed with LDHA knockdown.
• Cell viability decreases with LDHA knockdown under hypoxic conditions.

Clinical Implications

The findings suggest that targeting LDHA may influence tumor metabolism and viability in hypoxic environments. Understanding LDHA's role could inform therapeutic strategies in cancers exhibiting metabolic reprogramming.

Conclusion

This study highlights the role of LDHA in facilitating sorbitol and fructose metabolism in tumor cells under hypoxic conditions.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells
2. Blood Cancer Journal, 2016 -- Identifying Molecular Irregularities Associated with the Warburg Effect in Primary Refractory Diffuse Large B-Cell Lymphoma
3. Journal of Gastroenterology, 2025 -- The Critical Function of SFRP2 in Enhancing Glycolysis and Disease Advancement in High-Risk Colorectal Cancer Patients Based on a Glycometabolism Prognostic Model
4. npj Digital Medicine, 2025 -- Spatial Multi-Omics Enhanced by Machine Learning Reveals Lactate-Driven Therapeutic Targets and Reprogramming of the Tumor Microenvironment in Cancer
5. AJCC melanoma staging system, 2026 -- The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care
6. Frontiers, 2026 -- Fructose metabolism as an adaptive survival axis in pancreatic cancer: mechanistic insights and therapeutic implications
7. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care - PMC
8. Frontiers | Fructose metabolism as an adaptive survival axis in pancreatic cancer: mechanistic insights and therapeutic implications
9. Combination of vemurafenib with cobimetinib in BRAF V600E/K mutated melanoma patients to normalize LDH and optimize immunotherapy with nivolumab and ipilimumab (COWBOY): A randomized, open-label phase 2 clinical trial. | Journal of Clinical Oncology